Education&ScienceBig 5 Lung Diseases
Big 5 Lung Diseases

The Forum of International Respiratory Societies highlights five major lung diseases, the “Big 5”, which include asthma, chronic obstructive pulmonary disease (COPD), acute lower respiratory tract infections, lung cancer and tuberculosis. These diseases are among the most common causes of severe illness and death worldwide.
firsnet.org/images/publications/FIRS_Master_09202021.pdf
At the APSR 2022 Congress in Seoul, Republic of Korea, a workshop was held which brought together representatives from the APSR, Union APR, WHO SEA Region with the advice of the experts from WHO WPRO to address the “Big 5” and to contribute to the Sustainable Development Goals (SDGs) the WHO aims for.
The input was sought from successful groups that would address issues relating to Asthma, COPD, Lung Cancer, Tuberculosis and non-TB infections (the “Big 5”), with a focus on broad applicability to lower-middle income countries.
2022
- Towards regional progress: APSR 2022 Big Five Lung Diseases Workshop
- Toolkit of Primary Care Models (2022 Big 5 Lung Diseases Workshop Toolkit E-Request Form)
- Activating primary care COPD patients with multimorbidity (APCOM) programme
- All-hands on deck approach to Covid-19 vaccination – Oriental Mindoro
- Easy asthma clinic network
- Peak inspiratory flow rate guided inhalation therapy
- Improved clinical efficacy of indeterminant pulmonary nodules through lung cancer biomarker panel risk model and optimized diagnostics pathway for lung cancer
- Community respiratory centre/best practice model for the management of Big-5 respiratory illness
- Ubo patrol: a model of primary care for the Big 5 lung diseases in Dagupan City, Province of Pangasinan, Philippines
- Co-care for DM-latent infection of TB (CO4DLIT)
- The big five lung diseases in Ho Chi Minh City
- Booklet